RecruitingNot ApplicableNCT06865222

Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation

Variable Pulse Transcranial Magnetic Stimulation for Treatment of Post COVID Syndrome

Sponsor

Mayo Clinic

Enrollment

40 participants

Start Date

Jul 22, 2025

Study Type

INTERVENTIONAL

Conditions

Post COVID-19 Condition

Summary

The purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks and a procedure called Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 4 weeks for people with post covid-19 condition. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREElectromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks

The Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) will be administered through an FDA-approved Transcranial Magnetic Stimulation (TMS) medical device. Results of the baseline EEG will be uploaded to NoetherTech's EMBP software on the Mayo Clinic campus, and transferred to Noethertech servers for TMS parameter determination TMS treatment will be one 30 min session per day, 5 days per week (Monday-Friday), for 2 weeks.

PROCEDUREElectromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 4 weeks